Friday 6 November 2026 Export RNXT’s income statement to Excel — free account

RenovoRx, Inc.

RNXT Healthcare Biotechnology

RenovoRx, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.1 million, up 2,511.6% from fiscal 2024.

Revenue: +300.8%
EPS: 0.00%
Free cash flow: −12.7%

Quarter to September 2026, against a year earlier

Insider buying

1.14 0.05 −4.20%

Follow RNXT

Alert me

Market cap: $53.7M
P/E: 0.0×
Fwd P/E: −5.1×
Dividend yield: —
F-score: n/a
Altman Z: −8.04
Beneish M: 19.25
Dividend safety: n/a

Overview

	Sep '26 From the 10-Q filed 5 Nov	Jun '26	Mar '26	Dec '25	Older periods
ROE Full definition →	(149.98%)	(125.23%)	(100.47%)	(225.62%)	+8 more TTM periods Free account
ROA Full definition →	(110.14%)	(97.83%)	(81.85%)	(137.77%)
ROIC Full definition →	0.00%	0.00%	0.00%	0.00%
Return on Tangible Assets Full definition →	(132.69%)	(136.20%)	(103.30%)	(187.92%)
Average Days of Receivables Full definition →	80.07	88.66	68.64	45.18
Free Cash Flow per Share Full definition →	(0.25)	(0.25)	(0.30)	(0.31)
Free Cash Flow Full definition →	(12.22)	(11.94)	(11.30)	(10.97)
Capital Expenditures Full definition →	(0.09)	(0.07)	—	0.00
Other line items
Cash ROIC Full definition →	(62.09%)	(64.67%)	(47.83%)	(88.18%)
Accounts Receivable Turnover Full definition →	7.14	4.69	5.71	12.34
Accounts Payable Turnover Full definition →	0.49	0.40	0.30	0.47
Inventory Turnover Full definition →	1.45	0.00	0.00	0.00
Average Days of Payables Full definition →	772.84	1,026.27	1,288.44	891.85
Days of Inventory on Hand Full definition →	280.96	453.88	436.39	210.96
Tax Rate Full definition →	0.00	0.00	0.00	0.00
Research and Development Expense of Revenue Full definition →	186.78%	284.87%	393.22%	558.24%
Selling, General and Administrative Expense of Revenue Full definition →	386.31%	484.77%	549.76%	626.63%
Share Based Compensation of Revenue Full definition →	59.11%	76.97%	87.04%	112.82%
Operating CF/Net income Full definition →	0.93	0.97	0.92	0.98
Depreciation/Fixed assets Full definition →	0.13	0.06	0.03	0.17
Capex/Depreciation Full definition →	(7.50)	(11.83)	0.00	(1.00)
Revenue per Share Full definition →	0.06	0.04	0.04	0.03
Operating CF per Share Full definition →	(0.25)	(0.25)	(0.30)	(0.31)
Capex per Share Full definition →	0.00	0.00	0.00	0.00
Capex to Sales Full definition →	0.03	0.04	0.00	0.00

Show all line items

Columns are period end dates · fundamentals updated 5 Nov 2026

Stockrow Weekly